As healthcare spending is estimated to double by 2050, making up to 30 percent of GDP in some economies, the concept of nutrigenomics and personalised nutrition is increasingly becoming a priority.
The Asia-Pacific probiotics market is the largest globally, accounting for an estimated share of 38 percent in 2016.